B3GNT4

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, B3GNT4 mutation is significantly associated with the drug of many other genes, with 19 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible B3GNT4-associated genes across cancer lineages are Niraparib, AZD5438, and GSK2801. Each is linked with B3GNT4 in more than 1 cancer types. Because this analysis shows association rather than direction, both B3GNT4-to-partner and partner-to-B3GNT4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Niraparib grouped by B3GNT4-low versus B3GNT4-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (B3GNT4→partner) and Y-score (partner→B3GNT4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINENiraparib →+0.479+2.646.006.04731
LARGE_INTESTINEAZD5438 →+0.498+2.777.043.03831
LARGE_INTESTINEGSK2801 →+0.333+2.649.036.04631
LARGE_INTESTINEMasitinib →+0.499+2.652.020.04531
LARGE_INTESTINEPRIMA-1MET →+0.654+2.646.014.04721
LARGE_INTESTINESGC-CBP30 →+0.322+2.649.022.04621
Each partner links to its Q-omics profile. Showing the 6 strongest of 19 associations by consensus.

Niraparib by B3GNT4 expression — LARGE_INTESTINE

Box plot of Niraparib in B3GNT4-low vs B3GNT4-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration